ecqm.unions

Medical Induction Medication Union

Description:

Based On: Union77

Used By:

• CMS113v7

QDM Attributes

DinoprostoneAdministered

Clinical Focus: This set of values contains medications that represent Dinoprostone, commonly used in the delivery setting for induction of labor.

Data Element Scope: The intent of this data element is to identify patients who receive dinoprostone for the purpose of inducing labor. Using the Quality Data Model, this particular element will map to the 'Medication' category.

Inclusion Criteria: Include RxNorm codes that identify medications that contain Dinoprostone as the single ingredient. Drug forms consistent with vaginal administration should be included.

Exclusion Criteria: Medications that have multiple ingredients should be excluded. Drug forms that are not consistent with vaginal administration should not be included. The codes should be limited to those which are for human use and which are able to be prescribed in the US.

Subject constrained to the Dinoprostone

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

DinoprostoneAdministered

0..*

OxytocinAdministered

Clinical Focus: This set of values contains medications that represent Oxytocin.

Data Element Scope: The intent of this data element is to identify medications that represent Oxytocin. Using the Quality Data Model, this particular element will map to the 'Medication' category.

Inclusion Criteria: Include RxNorm codes that identify medications that represent Oxytocin as a single ingredient, administered in an injectable form.

Exclusion Criteria: Exclude drugs that have multiple ingredients. In addition, drugs with dose forms not consistent with injectable administration should not be included. The codes should be limited to those which are for human use and which are able to be prescribed in the US.

Subject constrained to the Oxytocin

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

OxytocinAdministered

0..*